| Full Name | Teresa Eick |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Home Health |
| Location | 12 Petra Ln, Albany, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285750729 | NPI | - | NPPES |
| 361295 | Other | NM | RN LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WH0200X | Registered Nurse - Home Health | 361295 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Teresa Eick, RN 75 Mountain View Rd, Nassau, NY 12123-3715 Ph: (518) 479-0662 | Teresa Eick, RN 12 Petra Ln, Albany, NY 12205-4973 Ph: (518) 452-0445 |
News Archive
Pfizer Inc. today announced, at the request of the U.S. Food and Drug Administration (FDA), the suspension of the chronic low back pain and painful diabetic peripheral neuropathy studies in the clinical program for the investigational compound tanezumab. Investigation of the compound continues in some areas of high unmet medical need, including cancer pain.
Data presented today from an analysis of samples from the European Diabetes Prevention Study (EDIPS) showed that the PreDx Diabetes Risk Score (DRS) is lowered by lifestyle intervention, which correlates to a reduction in the risk that patients will develop diabetes over time.
Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological research approach, was recognized today with the 2013 North American Drug Discovery Technology Innovation Award at the Frost & Sullivan Growth, Innovation and Leadership Awards Gala, the annual event by the global research organization that highlights the most promising new innovative technology across sectors.
Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in London, March 31 to April 3,demonstrating CEM-101's (solithromycin's) efficacy to be comparable to levofloxacin in a Phase 2 trial of patients with community-acquired bacterial infections.
An important development in understanding how the bacterium that causes pneumonia, meningitis and septicaemia remains harmlessly in the nose and throat has been discovered at the University of Liverpool's Institute of Infection and Global Health.
› Verified 1 days ago
Deborah Gelbman, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 12 Metro Park Rd, Suite 102, Albany, NY 12205 Phone: 518-437-0152 | |
Mrs. Barbara Irene Gaffuri, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 43 Bertha St, Albany, NY 12209 Phone: 518-475-6755 Fax: 518-475-6754 | |
Ms. Kelly N Miles, MS, RNC, NNP-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 43 New Scotland Ave, Albany, NY 12208 Phone: 518-262-9200 | |
Serena Gray, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 43 New Scotland Ave, Albany, NY 12208 Phone: 518-262-4000 | |
Marc Sopper, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 60 Academy Rd, Albany, NY 12208 Phone: 518-380-4766 Fax: 518-982-2972 | |
Kathryn Davis, RN, MS, CDE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1365 Washington Ave, Suite 300, Albany, NY 12206 Phone: 518-489-4704 Fax: 518-489-0512 | |
Mrs. Nicole Margaret Fiacco, BSN; RN, MS, PMHNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 920 Lark Dr, Albany, NY 12207 Phone: 518-465-4771 |